Debra Burdick
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Atrial Fibrillation Management and Outcomes, Ion Transport and Channel Regulation, Blood Coagulation and Thrombosis Mechanisms, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.(1992)997 cited
- → Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo(2014)724 cited
- → beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.(1994)334 cited
- → Small-molecule WNK inhibition regulates cardiovascular and renal function(2016)164 cited
- → Intracellular Aβ1-42 Aggregates Stimulate the Accumulation of Stable, Insoluble Amyloidogenic Fragments of the Amyloid Precursor Protein in Transfected Cells(1995)128 cited
- → Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, Aβ1–42, in differentiated PC12 cells(1997)112 cited
- → Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2003)75 cited
- → Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia(1995)54 cited
- → Discovery and Characterization of Allosteric WNK Kinase Inhibitors(2016)44 cited
- → Identification of a PCSK9-LDLR disruptor peptide with in vivo function(2021)44 cited